SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-075598
Filing Date
2022-03-15
Accepted
2022-03-15 11:09:29
Documents
1
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND V G.P. MANAGER, LTD.OMEGA FUND V GP, L.P.OMEGA FUND V, L.P.OTELLO STAMPACCHIAVINCENT OSSIPOW

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d278732dsc13da.htm SC 13D/A 175378
  Complete submission text file 0001193125-22-075598.txt   177225
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88651 | Film No.: 22739658
SIC: 2834 Pharmaceutical Preparations

Mailing Address 68 AVENUE DE LA LIBERTE LUXEMBOURG N4 L-1930
Business Address 68 AVENUE DE LA LIBERTE LUXEMBOURG N4 L-1930 617-502-6530
Global Life Bioventure V Sarl (Filed by) CIK: 0001773670 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A